When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Merkel cell carcinoma

Последний просмотренный: 11 Feb 2026
Last updated: 20 Sep 2024

Резюме

Определение

Анамнез и осмотр

Ключевые диагностические факторы

  • firm, nontender, red or pink-to-violaceous or skin-colored papule or subcutaneous nodule
  • rapidly growing lesion
Полная информация

Другие диагностические факторы

  • enlarged lymph nodes
  • ulceration or bleeding cutaneous lesion
  • small papules or nodules surrounding a primary lesion
Полная информация

Факторы риска

  • cumulative ultraviolet (UV) exposure
  • immunosuppression
  • advancing age
  • male sex
  • white skin
  • Merkel cell polyomavirus (MCPyV) infection with oncogenic transformation
Полная информация

Диагностические исследования

Исследования, которые показаны в первую очередь

  • biopsy and histopathologic assessment
  • dermoscopy
Полная информация

Исследования, проведение которых нужно рассмотреть

  • lymph node ultrasound
  • whole-body PET scan
  • CT scan with contrast chest/abdomen/pelvis (± neck)
  • brain MRI
  • fine-needle aspiration or core biopsy
  • sentinel lymph node biopsy (SLNB)
  • Merkel cell polyomavirus serology
Полная информация

Неотложные исследования

  • circulating tumor DNA (ctDNA) analysis

Алгоритм лечения

Острый

localized disease: stage I or II (T-any cN0 M0)

regional disease: stage IIIA

regional disease: unknown primary tumor with clinically apparent nodal disease

regional disease: stage IIIB

distant metastatic disease: stage IV

Составители

Авторы

Kelly Harms, MD, PhD

Associate Professor of Dermatology

Michigan Medicine

University of Michigan

Ann Arbor

MI

Раскрытие информации

KH is a panel member for NCCN guidelines on Merkel cell carcinoma. She serves as Chair of Professionalism and Ethics for the Michigan Dermatological Society Board of Directors. KH is married to Paul Harms, a co-author of research on Merkel cell carcinoma.

Alison Lee, MD, MHS

Clinical Fellow

Department of Dermatology

Michigan Medicine

University of Michigan

Ann Arbor

MI

Раскрытие информации

AL declares that she has no competing interests.

Рецензенты

Isaac Brownell, MD, PhD

Senior Investigator

Dermatology Branch

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institutes of Health (NIH)

Bethesda

MD

Раскрытие информации

IB declares that he has no competing interests.

Zoe Venables, MbChB, MMedSci, MRCP

Clinical Associate Professor and Consultant Dermatologist

Norfolk and Norwich University Hospitals NHS Foundation Trust

Norwich

UK

Раскрытие информации

ZV declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Merkel cell carcinoma [internet publication].Полный текст

Gauci ML, Aristei C, Becker JC, et al; the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). ​Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - update 2022. Eur J Cancer. 2022 Aug:171:203-31.Полный текст  Аннотация

Lugowska I, Becker JC, Ascierto PA, et al; ESMO Guidelines Committee. Merkel-cell carcinoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open. 2024 May;9(5):102977.Полный текст  Аннотация

Silk AW, Barker CA, Bhatia S, et al. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer. J Immunother Cancer. 2022 Jul;10(7):e004434.Полный текст  Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности